Fagan, A. M., Mintun, M. A., Shah, A. R., Aldea, P., Roe, C. M., Mach, R. H., . . . Holtzman, D. M. (2009). Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: Implications for future clinical trials of Alzheimer's disease. WILEY-VCH Verlag.

Fagan, Anne M., Mark A. Mintun, Aarti R. Shah, Patricia Aldea, Catherine M. Roe, Robert H. Mach, Daniel Marcus, John C. Morris, and David M. Holtzman. Cerebrospinal Fluid Tau and Ptau(181) Increase With Cortical Amyloid Deposition in Cognitively Normal Individuals: Implications for Future Clinical Trials of Alzheimer's Disease. WILEY-VCH Verlag, 2009.

Fagan, Anne M., et al. Cerebrospinal Fluid Tau and Ptau(181) Increase With Cortical Amyloid Deposition in Cognitively Normal Individuals: Implications for Future Clinical Trials of Alzheimer's Disease. WILEY-VCH Verlag, 2009.